Skip to main navigation Skip to search Skip to main content

Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?

  • Navid Sobhani
  • , Silvia P Corona
  • , Giandomenico Roviello
  • , Stefan Bagby
  • , Alberto D'Angelo
  • , Giandomenico Iezzi
  • , Daniele Generali
  • University of Trieste
  • AstraZeneca, Cambridge
  • Institute for Research in Biomedicine (IRB)

Research output: Contribution to journalComment/debatepeer-review

2   Link opens in a new tab Citations (SciVal)
Original languageEnglish
Pages (from-to)1327-1330
Number of pages4
JournalFuture oncology (London, England)
Volume16
Issue number19
Early online date12 May 2020
DOIs
Publication statusPublished - 31 Jul 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • checkpoint inhibitors
  • immune markers
  • immune-gene signature
  • solid tumors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this